Good thoughts, thanks. And with that upcoming 1600 pt safety study, Dr Jay was effectively front-running these changes, whether knowingly or not. Once a drug's safety is firmly established, I think a Makary-led FDA might be disposed to grant early approval with post-approval followup studies. Halleluja if so, and not just for us.